A patent database that serves public health
Pat-INFORMED is the name of the most recent initiative which WIPO launched on 3 October 2017 in Geneva at the WIPO annual general meeting in cooperation with the research-based pharmaceutical industry.
According to the Media Release from the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) the Pat-INFORMED database will be made publicly available mid-2018. The aim of the database is to provide information primarily to procurement agencies concerning which medications are patented where, and where they are not. This information helps in the purchasing and selection of medicinal products. Initially, the database is limited to a few important medicinal products for the treatment of cancer, hepatitis C, HIV, diabetes, the cardiovascular and respiratory systems as well as all medicinal products on the WHO list of essential medicinal products.
This is a prime example of how the patent system can be implemented for direct benefit of public health.
08.06.2018 | IP news
Winners of the European Inventor Award 2018 announced: The Swiss physicist Ursula Keller receives lifetime achievement award
Better international protection for Swiss quality products
29.05.2018 | Partners and initiatives
The start-up grüengahts wins the IPI’s IP Management Award 2018
Info event on using strategic patent analyses on 11.4.2018 in Zurich
14.02.2018 | Event
Stakeholder Discussions on: Innovation, availability and affordability of medical products. Can we achieve it all?
Séminaire IPI / LES: «développements récents en droit des marques», jeudi le 9 novembre 2017 au Novotel Genève
Patents and pharmaceuticals - Public event at the IPI in collaboration with the European Patent Office